The magictome group | The conventional group | P value | |
---|---|---|---|
n = 44 | n = 75 | ||
Age, median (range), year | 72.0 (42–89) | 74.0 (36–93) | 0.36 |
Sex (male/female), n | 25 /19 | 48/27 | 0.56 |
Indication of ERCP, n (%) | |||
CBD stone | 24 (54.5) | 38 (50.7) | 0.83 |
Neoplasm | 16 (36.4) | 22 (29.3) | 0.56 |
Others | 4 (9.1) | 15 (20.0) | 0.13 |
ASA ≥ 3, n (%) | 4 (9.1) | 9 (12.0) | 0.77 |
Anticoagulant use, n (%) | 7 (15.9) | 17 (22.7) | 0.52 |
Duodenum diverticulum, n (%) | 3 (6.8) | 5 (6.7) | 1.0 |
Oral protrusion of the papilla, mm (mean ± SD) | 10.4 ± 4.9 | 9.7 ± 2.9 | 0.33 |
Purpose of ERCP, n (%) | |||
EST | 27 (61.4) | 39 (52.0) | 0.42 |
EPBD | 1 (2.3) | 6 (8.0) | 0.26 |
IDUS | 15 (34.1) | 16 (21.3) | 0.19 |
EBD | 20 (45.5) | 31 (41.3) | 0.81 |
Biopsy | 2 (4.5) | 3 (4.0) | 1.0 |
Cases performed by trainee, n (%) | 22 (50.0) | 32 (42.7) | 0.56 |